期刊论文详细信息
Genome Medicine
Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
Research
Matthew Hoare1  Carolina H. Chung2  J. William O. Ballard3  Aikaterini Tourna4  Gabriella Assante4  Shilpa Chokshi4  Kowsar A. Isse4  Ugo Soffientini4  Neil A. Youngson5  Celine Filippi6  Anil Dhawan6  Sriram Chandrasekaran7  Steven G. Rozen8  Mo Liu8  Margaret J. Morris9  Jasmine L. Banks1,10  Nigel Turner1,10  Stanley Ng1,11  Peter Campbell1,11 
[1] CRUK Cambridge Institute, Cambridge, UK;Department of Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK;Department of Biomedical Engineering, University of Michigan, 48109, Ann Arbor, MI, USA;Department of Ecology, Environment and Evolution, La Trobe University, 3086, Bundoora, Melbourne, VIC, Australia;Institute of Hepatology, Foundation for Liver Research, 111 Coldharbour Lane, SE5 9NT, London, UK;King’s College London, Faculty of Life Sciences and Medicine, London, UK;Institute of Hepatology, Foundation for Liver Research, 111 Coldharbour Lane, SE5 9NT, London, UK;King’s College London, Faculty of Life Sciences and Medicine, London, UK;UNSW Sydney, Sydney, Australia;Institute of Liver Studies, King’s College Hospital, London, UK;Program in Chemical Biology, University of Michigan, 48109, Ann Arbor, MI, USA;Center for Bioinformatics and Computational Medicine, 48109, Ann Arbor, MI, USA;Department of Biomedical Engineering, University of Michigan, 48109, Ann Arbor, MI, USA;Rogel Cancer Center, University of Michigan Medical School, 48109, Ann Arbor, MI, USA;Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore;UNSW Sydney, Sydney, Australia;UNSW Sydney, Sydney, Australia;Cellular Bioenergetics Laboratory, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia;Wellcome Trust Sanger Institute, Cambridge, UK;
关键词: Steatosis;    Histone acetylation;    Hepatocellular carcinoma;    NAFLD;    ARLD;    Telomerase;   
DOI  :  10.1186/s13073-022-01071-5
 received in 2021-08-10, accepted in 2022-06-16,  发布年份 2022
来源: Springer
PDF
【 摘 要 】

BackgroundThe incidence of non-alcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC) is increasing worldwide, but the steps in precancerous hepatocytes which lead to HCC driver mutations are not well understood. Here we provide evidence that metabolically driven histone hyperacetylation in steatotic hepatocytes can increase DNA damage to initiate carcinogenesis.MethodsGlobal epigenetic state was assessed in liver samples from high-fat diet or high-fructose diet rodent models, as well as in cultured immortalized human hepatocytes (IHH cells). The mechanisms linking steatosis, histone acetylation and DNA damage were investigated by computational metabolic modelling as well as through manipulation of IHH cells with metabolic and epigenetic inhibitors. Chromatin immunoprecipitation and next-generation sequencing (ChIP-seq) and transcriptome (RNA-seq) analyses were performed on IHH cells. Mutation locations and patterns were compared between the IHH cell model and genome sequence data from preneoplastic fatty liver samples from patients with alcohol-related liver disease and NAFLD.ResultsGenome-wide histone acetylation was increased in steatotic livers of rodents fed high-fructose or high-fat diet. In vitro, steatosis relaxed chromatin and increased DNA damage marker γH2AX, which was reversed by inhibiting acetyl-CoA production. Steatosis-associated acetylation and γH2AX were enriched at gene clusters in telomere-proximal regions which contained HCC tumour suppressors in hepatocytes and human fatty livers. Regions of metabolically driven epigenetic change also had increased levels of DNA mutation in non-cancerous tissue from NAFLD and alcohol-related liver disease patients. Finally, genome-scale network modelling indicated that redox balance could be a key contributor to this mechanism.ConclusionsAbnormal histone hyperacetylation facilitates DNA damage in steatotic hepatocytes and is a potential initiating event in hepatocellular carcinogenesis.

【 授权许可】

CC BY   
© The Author(s) 2022. corrected publication 2023

【 预 览 】
附件列表
Files Size Format View
RO202308159705066ZK.pdf 3409KB PDF download
41116_2023_36_Article_IEq504.gif 1KB Image download
Fig. 4 190KB Image download
41116_2023_36_Article_IEq627.gif 1KB Image download
41116_2023_36_Article_IEq631.gif 1KB Image download
MediaObjects/12888_2023_4756_MOESM5_ESM.docx 301KB Other download
41116_2023_36_Article_IEq653.gif 1KB Image download
41116_2023_36_Article_IEq655.gif 1KB Image download
41116_2023_36_Article_IEq663.gif 1KB Image download
41116_2023_36_Article_IEq684.gif 1KB Image download
【 图 表 】

41116_2023_36_Article_IEq684.gif

41116_2023_36_Article_IEq663.gif

41116_2023_36_Article_IEq655.gif

41116_2023_36_Article_IEq653.gif

41116_2023_36_Article_IEq631.gif

41116_2023_36_Article_IEq627.gif

Fig. 4

41116_2023_36_Article_IEq504.gif

【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  • [50]
  • [51]
  • [52]
  • [53]
  • [54]
  • [55]
  • [56]
  • [57]
  • [58]
  • [59]
  • [60]
  文献评价指标  
  下载次数:8次 浏览次数:2次